Drug intelligence / Profile preview

sporamin

Development stage
Unknown
Lead developer
The 153th People's Liberation Army Hospital
Modality
Recombinant Proteins and Enzymes
Administration
Oral
01

Overview

Sporamin is the primary storage protein found in the tuberous roots of the sweet potato (*Ipomoea batatas*). It is a Kunitz-type trypsin inhibitor that has demonstrated significant antineoplastic properties, particularly in the context of colorectal cancer. The protein acts by inhibiting protease activity and modulating key oncogenic signaling pathways, such as the Wnt/β-catenin pathway, which leads to the induction of apoptosis and the suppression of tumor cell proliferation and metastasis. Clinical research, notably conducted by the 153th People's Liberation Army Hospital in China, has investigated sporamin as an adjuvant therapeutic agent in combination with standard chemotherapy (e.g., fluorouracil) for patients with stage II colorectal cancer following surgical resection.

Brand names
Sporam
Other names
Sweet potato storage proteinIpomoea batatas sporamin
02

Targets

CTNNB1 (Beta-catenin)PRSS1 (Trypsin family)

Beyond the preview

Go deeper on sporamin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on sporamin.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call